Which has preferable earnings and valuation, TRLV or COGT?

Trulieve Cannabis has higher revenue and earnings than Cogent Biosciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Trulieve Cannabis $1.17B 1.37 N/A N/A N/A Cogent Biosciences N/A N/A -$328.94M -$2.17 N/A

Is TRLV or COGT more profitable?

Trulieve Cannabis' return on equity of 0.00% beat Cogent Biosciences' return on equity. Company Net Margins Return on Equity Return on Assets Trulieve Cannabis N/A N/A N/A Cogent Biosciences N/A -104.27% -54.64%

Does the media prefer TRLV or COGT?

In the previous week, Cogent Biosciences had 10 more articles in the media than Trulieve Cannabis. MarketBeat recorded 12 mentions for Cogent Biosciences and 2 mentions for Trulieve Cannabis. Cogent Biosciences' average media sentiment score of 1.75 beat Trulieve Cannabis' score of -1.00 indicating that Cogent Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Trulieve Cannabis 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Cogent Biosciences 10 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has better earnings & valuation, TRLV or PTCT?

PTC Therapeutics has higher revenue and earnings than Trulieve Cannabis. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Trulieve Cannabis $1.17B 1.37 N/A N/A N/A PTC Therapeutics $1.73B 3.61 $682.64M -$2.33 N/A

Does the media prefer TRLV or PTCT?

In the previous week, PTC Therapeutics had 10 more articles in the media than Trulieve Cannabis. MarketBeat recorded 12 mentions for PTC Therapeutics and 2 mentions for Trulieve Cannabis. PTC Therapeutics' average media sentiment score of 0.78 beat Trulieve Cannabis' score of -1.00 indicating that PTC Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Trulieve Cannabis 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative PTC Therapeutics 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, XENE or TRLV?

Trulieve Cannabis has higher revenue and earnings than Xenon Pharmaceuticals. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Xenon Pharmaceuticals $7.50M 837.03 -$345.91M -$4.70 N/A Trulieve Cannabis $1.17B 1.37 N/A N/A N/A

Is XENE or TRLV more profitable?

Trulieve Cannabis' return on equity of 0.00% beat Xenon Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Xenon Pharmaceuticals N/A -49.23% -46.42% Trulieve Cannabis N/A N/A N/A

Does the media refer more to XENE or TRLV?

In the previous week, Xenon Pharmaceuticals had 12 more articles in the media than Trulieve Cannabis. MarketBeat recorded 14 mentions for Xenon Pharmaceuticals and 2 mentions for Trulieve Cannabis. Xenon Pharmaceuticals' average media sentiment score of 1.50 beat Trulieve Cannabis' score of -1.00 indicating that Xenon Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Xenon Pharmaceuticals 13 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Trulieve Cannabis 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative

Which has stronger valuation and earnings, CNTA or TRLV?

Trulieve Cannabis has higher revenue and earnings than Centessa Pharmaceuticals. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Centessa Pharmaceuticals N/A N/A -$197.53M -$1.79 N/A Trulieve Cannabis $1.17B 1.37 N/A N/A N/A

Is CNTA or TRLV more profitable?

Trulieve Cannabis' return on equity of 0.00% beat Centessa Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Centessa Pharmaceuticals N/A -60.37% -44.17% Trulieve Cannabis N/A N/A N/A

Which has better valuation and earnings, TRLV or CGON?

Trulieve Cannabis has higher revenue and earnings than CG Oncology. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Trulieve Cannabis $1.17B 1.37 N/A N/A N/A CG Oncology $5.07M 1,263.11 -$160.99M -$2.33 N/A

Is TRLV or CGON more profitable?

Trulieve Cannabis' return on equity of 0.00% beat CG Oncology's return on equity. Company Net Margins Return on Equity Return on Assets Trulieve Cannabis N/A N/A N/A CG Oncology N/A -23.33% -22.24%

Does the media refer more to TRLV or CGON?

In the previous week, CG Oncology had 6 more articles in the media than Trulieve Cannabis. MarketBeat recorded 8 mentions for CG Oncology and 2 mentions for Trulieve Cannabis. CG Oncology's average media sentiment score of 1.40 beat Trulieve Cannabis' score of -1.00 indicating that CG Oncology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Trulieve Cannabis 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative CG Oncology 5 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Trulieve Cannabis (TRLV) Competitors

$8.33 +0.00 (+0.05%)

Closing price 03:59 PM Eastern

Extended Trading

$8.32 -0.02 (-0.23%)

As of 04:45 PM Eastern

Compare

TRLV vs. COGT, PTCT, XENE, CNTA, and CGON

Should you buy Trulieve Cannabis stock or one of its competitors? MarketBeat compares Trulieve Cannabis with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Trulieve Cannabis include Cogent Biosciences (COGT), PTC Therapeutics (PTCT), Xenon Pharmaceuticals (XENE), Centessa Pharmaceuticals (CNTA), and CG Oncology (CGON). These companies are all part of the "pharmaceutical products" industry.

How does Trulieve Cannabis compare to Cogent Biosciences?

Trulieve Cannabis (NYSE:TRLV) and Cogent Biosciences (NASDAQ:COGT) are both pharmaceutical products companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends.

Trulieve Cannabis currently has a consensus price target of $15.00, indicating a potential upside of 79.99%. Cogent Biosciences has a consensus price target of $45.90, indicating a potential upside of 12.86%. Given Trulieve Cannabis' higher probable upside, analysts plainly believe Trulieve Cannabis is more favorable than Cogent Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Trulieve Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cogent Biosciences	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	2 Strong Buy rating(s)	2.85

Trulieve Cannabis has higher revenue and earnings than Cogent Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Trulieve Cannabis	$1.17B	1.37	N/A	N/A	N/A
Cogent Biosciences	N/A	N/A	-$328.94M	-$2.17	N/A

In the previous week, Cogent Biosciences had 10 more articles in the media than Trulieve Cannabis. MarketBeat recorded 12 mentions for Cogent Biosciences and 2 mentions for Trulieve Cannabis. Cogent Biosciences' average media sentiment score of 1.75 beat Trulieve Cannabis' score of -1.00 indicating that Cogent Biosciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Trulieve Cannabis	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
Cogent Biosciences	10 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Trulieve Cannabis' return on equity of 0.00% beat Cogent Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Trulieve Cannabis	N/A	N/A	N/A
Cogent Biosciences	N/A	-104.27%	-54.64%

Summary

Cogent Biosciences beats Trulieve Cannabis on 5 of the 9 factors compared between the two stocks.

How does Trulieve Cannabis compare to PTC Therapeutics?

Trulieve Cannabis (NYSE:TRLV) and PTC Therapeutics (NASDAQ:PTCT) are both pharmaceutical products companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, profitability, media sentiment, analyst recommendations, risk and institutional ownership.

PTC Therapeutics has higher revenue and earnings than Trulieve Cannabis.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Trulieve Cannabis	$1.17B	1.37	N/A	N/A	N/A
PTC Therapeutics	$1.73B	3.61	$682.64M	-$2.33	N/A

Trulieve Cannabis currently has a consensus price target of $15.00, indicating a potential upside of 79.99%. PTC Therapeutics has a consensus price target of $92.29, indicating a potential upside of 22.41%. Given Trulieve Cannabis' higher possible upside, equities analysts plainly believe Trulieve Cannabis is more favorable than PTC Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Trulieve Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
PTC Therapeutics	2 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	2 Strong Buy rating(s)	2.80

Trulieve Cannabis has a net margin of 0.00% compared to PTC Therapeutics' net margin of -22.58%. Trulieve Cannabis' return on equity of 0.00% beat PTC Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Trulieve Cannabis	N/A	N/A	N/A
PTC Therapeutics	-22.58%	-362.45%	-6.76%

In the previous week, PTC Therapeutics had 10 more articles in the media than Trulieve Cannabis. MarketBeat recorded 12 mentions for PTC Therapeutics and 2 mentions for Trulieve Cannabis. PTC Therapeutics' average media sentiment score of 0.78 beat Trulieve Cannabis' score of -1.00 indicating that PTC Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Trulieve Cannabis	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
PTC Therapeutics	7 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

PTC Therapeutics beats Trulieve Cannabis on 7 of the 11 factors compared between the two stocks.

How does Trulieve Cannabis compare to Xenon Pharmaceuticals?

Xenon Pharmaceuticals (NASDAQ:XENE) and Trulieve Cannabis (NYSE:TRLV) are both pharmaceutical products companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, risk, institutional ownership, earnings and analyst recommendations.

95.5% of Xenon Pharmaceuticals shares are owned by institutional investors. 2.9% of Xenon Pharmaceuticals shares are owned by company insiders. Comparatively, 3.8% of Trulieve Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Xenon Pharmaceuticals currently has a consensus target price of $77.20, suggesting a potential upside of 18.88%. Trulieve Cannabis has a consensus target price of $15.00, suggesting a potential upside of 79.99%. Given Trulieve Cannabis' higher possible upside, analysts clearly believe Trulieve Cannabis is more favorable than Xenon Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Xenon Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	14 Buy rating(s)	2 Strong Buy rating(s)	3.00
Trulieve Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Trulieve Cannabis has higher revenue and earnings than Xenon Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Xenon Pharmaceuticals	$7.50M	837.03	-$345.91M	-$4.70	N/A
Trulieve Cannabis	$1.17B	1.37	N/A	N/A	N/A

In the previous week, Xenon Pharmaceuticals had 12 more articles in the media than Trulieve Cannabis. MarketBeat recorded 14 mentions for Xenon Pharmaceuticals and 2 mentions for Trulieve Cannabis. Xenon Pharmaceuticals' average media sentiment score of 1.50 beat Trulieve Cannabis' score of -1.00 indicating that Xenon Pharmaceuticals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Xenon Pharmaceuticals	13 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Trulieve Cannabis	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

Trulieve Cannabis' return on equity of 0.00% beat Xenon Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Xenon Pharmaceuticals	N/A	-49.23%	-46.42%
Trulieve Cannabis	N/A	N/A	N/A

Summary

Xenon Pharmaceuticals beats Trulieve Cannabis on 7 of the 12 factors compared between the two stocks.

How does Trulieve Cannabis compare to Centessa Pharmaceuticals?

Centessa Pharmaceuticals (NASDAQ:CNTA) and Trulieve Cannabis (NYSE:TRLV) are both pharmaceutical products companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, analyst recommendations, profitability, risk, valuation and earnings.

In the previous week, Trulieve Cannabis had 2 more articles in the media than Centessa Pharmaceuticals. MarketBeat recorded 2 mentions for Trulieve Cannabis and 0 mentions for Centessa Pharmaceuticals. Centessa Pharmaceuticals' average media sentiment score of 0.00 beat Trulieve Cannabis' score of -1.00 indicating that Centessa Pharmaceuticals is being referred to more favorably in the media.

Company	Overall Sentiment
Centessa Pharmaceuticals	Neutral
Trulieve Cannabis	Negative

Trulieve Cannabis has higher revenue and earnings than Centessa Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Centessa Pharmaceuticals	N/A	N/A	-$197.53M	-$1.79	N/A
Trulieve Cannabis	$1.17B	1.37	N/A	N/A	N/A

Trulieve Cannabis' return on equity of 0.00% beat Centessa Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Centessa Pharmaceuticals	N/A	-60.37%	-44.17%
Trulieve Cannabis	N/A	N/A	N/A

82.0% of Centessa Pharmaceuticals shares are owned by institutional investors. 4.1% of Centessa Pharmaceuticals shares are owned by insiders. Comparatively, 3.8% of Trulieve Cannabis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Centessa Pharmaceuticals currently has a consensus price target of $41.33, indicating a potential upside of 2.06%. Trulieve Cannabis has a consensus price target of $15.00, indicating a potential upside of 79.99%. Given Trulieve Cannabis' higher probable upside, analysts plainly believe Trulieve Cannabis is more favorable than Centessa Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Centessa Pharmaceuticals	1 Sell rating(s)	9 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.21
Trulieve Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Centessa Pharmaceuticals and Trulieve Cannabis tied by winning 5 of the 10 factors compared between the two stocks.

How does Trulieve Cannabis compare to CG Oncology?

Trulieve Cannabis (NYSE:TRLV) and CG Oncology (NASDAQ:CGON) are both pharmaceutical products companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership, media sentiment and valuation.

In the previous week, CG Oncology had 6 more articles in the media than Trulieve Cannabis. MarketBeat recorded 8 mentions for CG Oncology and 2 mentions for Trulieve Cannabis. CG Oncology's average media sentiment score of 1.40 beat Trulieve Cannabis' score of -1.00 indicating that CG Oncology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Trulieve Cannabis	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
CG Oncology	5 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

26.6% of CG Oncology shares are owned by institutional investors. 3.8% of Trulieve Cannabis shares are owned by insiders. Comparatively, 4.8% of CG Oncology shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Trulieve Cannabis has higher revenue and earnings than CG Oncology.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Trulieve Cannabis	$1.17B	1.37	N/A	N/A	N/A
CG Oncology	$5.07M	1,263.11	-$160.99M	-$2.33	N/A

Trulieve Cannabis presently has a consensus target price of $15.00, suggesting a potential upside of 79.99%. CG Oncology has a consensus target price of $81.73, suggesting a potential upside of 12.54%. Given Trulieve Cannabis' higher possible upside, equities research analysts plainly believe Trulieve Cannabis is more favorable than CG Oncology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Trulieve Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
CG Oncology	1 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.71

Trulieve Cannabis' return on equity of 0.00% beat CG Oncology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Trulieve Cannabis	N/A	N/A	N/A
CG Oncology	N/A	-23.33%	-22.24%

Summary

CG Oncology beats Trulieve Cannabis on 7 of the 11 factors compared between the two stocks.

Get Trulieve Cannabis News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TRLV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TRLV vs. The Competition

Export

Metric	Trulieve Cannabis	Medicinal Chemicals Industry	Manufacturing Sector	NYSE Exchange
Market Cap	$1.60B	$1.34B	$6.61B	$23.76B
Dividend Yield	N/A	N/A	38.15%	4.21%
P/E Ratio	N/A	N/A	23.61	31.10
Price / Sales	1.37	1.97	159.84	166.18
Price / Cash	N/A	0.27	30.27	18.54
Price / Book	N/A	298.52	12.99	4.81
Net Income	N/A	-$1.41M	$120.31M	$1.07B
7 Day Performance	-5.67%	-4.70%	-2.38%	0.57%
1 Month Performance	-6.62%	-7.25%	-4.31%	0.89%
1 Year Performance	N/A	-56.74%	10.09%	15.18%

Trulieve Cannabis Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TRLV Trulieve Cannabis	2.9053 of 5 stars	$8.33 +0.0%	$15.00 +80.0%	N/A	$1.60B	$1.17B	N/A	9,000	Negative News Short Interest Increase
COGT Cogent Biosciences	1.8863 of 5 stars	$39.64 +3.5%	$45.90 +15.8%	+235.0%	$6.54B	N/A	N/A	80	News Coverage Upcoming Earnings
PTCT PTC Therapeutics	4.3331 of 5 stars	$78.50 +0.6%	$92.29 +17.6%	+69.4%	$6.47B	$1.73B	N/A	1,410	Upcoming Earnings Short Interest Decrease
XENE Xenon Pharmaceuticals	3.096 of 5 stars	$66.74 +1.1%	$77.20 +15.7%	+117.1%	$6.38B	$7.50M	N/A	210	News Coverage Positive News
CNTA Centessa Pharmaceuticals	0.6401 of 5 stars	$40.50 flat	$41.33 +2.1%	N/A	$6.27B	N/A	N/A	200	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:TRLV) was last updated on 7/28/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trulieve Cannabis (TRLV) Competitors

TRLV vs. COGT, PTCT, XENE, CNTA, and CGON

How does Trulieve Cannabis compare to Cogent Biosciences?

Summary

How does Trulieve Cannabis compare to PTC Therapeutics?

Summary

How does Trulieve Cannabis compare to Xenon Pharmaceuticals?

Summary

How does Trulieve Cannabis compare to Centessa Pharmaceuticals?

Summary

How does Trulieve Cannabis compare to CG Oncology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TRLV vs. The Competition

Trulieve Cannabis Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Trulieve Cannabis (TRLV) Competitors

TRLV vs. COGT, PTCT, XENE, CNTA, and CGON

How does Trulieve Cannabis compare to Cogent Biosciences?

Do analysts recommend TRLV or COGT?

Which has preferable earnings and valuation, TRLV or COGT?

Does the media prefer TRLV or COGT?

Is TRLV or COGT more profitable?

Summary

How does Trulieve Cannabis compare to PTC Therapeutics?

Which has better earnings & valuation, TRLV or PTCT?

Do analysts recommend TRLV or PTCT?

Is TRLV or PTCT more profitable?

Does the media prefer TRLV or PTCT?

Summary

How does Trulieve Cannabis compare to Xenon Pharmaceuticals?

Do institutionals and insiders have more ownership in XENE or TRLV?

Do analysts rate XENE or TRLV?

Which has better earnings and valuation, XENE or TRLV?

Does the media refer more to XENE or TRLV?

Is XENE or TRLV more profitable?

Summary

How does Trulieve Cannabis compare to Centessa Pharmaceuticals?

Does the media refer more to CNTA or TRLV?

Which has stronger valuation and earnings, CNTA or TRLV?

Is CNTA or TRLV more profitable?

Do institutionals and insiders believe in CNTA or TRLV?

Do analysts rate CNTA or TRLV?

Summary

How does Trulieve Cannabis compare to CG Oncology?

Does the media refer more to TRLV or CGON?

Do institutionals & insiders hold more shares of TRLV or CGON?

Which has better valuation and earnings, TRLV or CGON?

Do analysts prefer TRLV or CGON?

Is TRLV or CGON more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TRLV vs. The Competition

Trulieve Cannabis Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools